Rachel Fremont is a Psychiatry physician affiliated with Icahn School of Medicine at Mount Sinai. OpenAlex indexes 37 publications with 1,362 citations (h-index 11); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1051 Riverside Dr # 103
Department Of Psychiatry Graduate Medical Education
New York, NY 100321007
Telephone
646-774-6300Provider last certified this registry record 6 May 2021.
Clinical trials
- Psilocybin With Pimavanserin Compared to Psilocybin Alone for the Treatment of Major Depressive Disorder
Sponsor: Icahn School of Medicine at Mount Sinai
- Single-dose Ketamine Treatment to Improve Depression in Mild Cognitive Impairment
Sponsor: Icahn School of Medicine at Mount Sinai
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
100%Central Nervous System Stimulant100%Dextroamphetamine-Amphetamine100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2010–2013 per NIH RePORTER. The latest:
- The Role of a Cerebello-Thalamo-Basal Ganglia Pathway in Dystonia
Albert Einstein College of Medicine
FY2013$20,196F30NS071665 - The Role of a Cerebello-Thalamo-Basal Ganglia Pathway in Dystonia
Albert Einstein College of Medicine
FY2012$33,664F30NS071665 - The Role of a Cerebello-Thalamo-Basal Ganglia Pathway in Dystonia
Albert Einstein College of Medicine
FY2011$40,500F30NS071665
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- KET-MCI: A Pilot Safety and Tolerability Study of Single Infusion Intravenous Ketamine for Older Adults with Depression and Mild Cognitive Impairment
American Journal of Geriatric Psychiatry
2026 - Feasibility and tolerability of low-dose lithium for the treatment of agitation and abnormal motor behaviors in Frontotemporal Dementia
International Review of Psychiatry
2025 - Neuropsychiatric and behavioral symptom clusters in frontotemporal dementia
Journal of Alzheimer s Disease Reports
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Jonathan Halperin, MD
Icahn School of Medicine at Mount Sinai
Fred Lublin, MD
Icahn School of Medicine at Mount Sinai
Sundar Jagannath, MD
Icahn School of Medicine at Mount Sinai
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”